Cisplatin
- Generic Name
- Cisplatin
- Brand Names
- Platinol
- Drug Type
- Small Molecule
- Chemical Formula
- Cl2H6N2Pt
- CAS Number
- 15663-27-1
- Unique Ingredient Identifier
- Q20Q21Q62J
- Background
Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
- Indication
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
- Associated Conditions
- Advanced Ovarian Cancer, Ovarian Cancer Metastatic, Advanced Bladder cancer, Advanced Testicular cancer, Metastatic Testicular cancer
- Associated Therapies
- -
Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-05-07
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 89
- Registration Number
- NCT00059826
- Locations
- 🇺🇸
University of Florida Shands Cancer Center, Gainesville, Florida, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
🇺🇸James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx
- Conditions
- First Posted Date
- 2003-04-30
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 160
- Registration Number
- NCT00003627
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
🇫🇷Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier, France
🇫🇷Institut Jean Godinot, Reims, France
Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-04-16
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 400
- Registration Number
- NCT00002822
- Locations
- 🇬🇧
Medical Research Council Clinical Trials Unit, London, England, United Kingdom
Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
- Conditions
- First Posted Date
- 2003-04-11
- Last Posted Date
- 2012-07-02
- Target Recruit Count
- 90
- Registration Number
- NCT00002669
- Locations
- 🇮🇹
Istituto Europeo Di Oncologia, Milano, Italy
🇦🇹Landeskrankenanstalten - Salzburg, Salzburg, Austria
🇧🇪U.Z. Gasthuisberg, Leuven, Belgium
Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma
- Conditions
- First Posted Date
- 2003-04-10
- Last Posted Date
- 2012-09-24
- Target Recruit Count
- 214
- Registration Number
- NCT00002539
- Locations
- 🇳🇱
University Medical Center Nijmegen, Nijmegen, Netherlands
🇳🇱Academisch Ziekenhuis Utrecht, Utrecht, Netherlands
🇧🇪Institut Jules Bordet, Brussels (Bruxelles), Belgium
Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-04-10
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 429
- Registration Number
- NCT00002550
- Locations
- 🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
🇺🇸Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States
🇺🇸Indiana University Cancer Center, Indianapolis, Indiana, United States
BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 27
- Registration Number
- NCT00057850
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2017-02-17
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 68
- Registration Number
- NCT00057785
- Locations
- 🇺🇸
Siteman Cancer Center at Barnes-Jewish Hospital, St Louis, Missouri, United States
🇺🇸Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸Radiological Associates of Sacramento Medical Group, Incorporated, Sacramento, California, United States
S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
- Conditions
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2012-06-13
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00057928
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸Veterans Affairs Medical Center - Little Rock (McClellan), Little Rock, Arkansas, United States
🇺🇸Mayo Clinic, Jacksonville, Florida, United States
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 140
- Registration Number
- NCT00057837
- Locations
- 🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States
🇺🇸St. Luke's Regional Medical Center, Sioux City, Iowa, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.